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In vitro decrease of glomerular heparan sulfate by lymphocytes [2, 5] was described. Various studies have shown modifi-
from idiopathic nephrotic syndrome patients. cations of lymphocyte counts and lymphocyte functions
Background. Lymphocytes are involved in the physiopatho- in patients with INS. Modifications of subclasses of lym-logic mechanism of idiopathic nephrotic syndrome (INS). We
phocytes were described by some authors [6–9], particu-have recently demonstrated that plasma from patients with
larly a decrease in CD4 versus CD8 cells, and a modifica-INS decreases human glomerular epithelial cell (GEC) glyco-
saminoglycans (GAGs), particularly heparan sulfates (HS) in tion of the equilibrium between Th1 and Th2 [9], although
vitro. In this study we investigate the effect of peripheral blood these findings contradicted a previous study [10]. More-
lymphocytes (PBL) from INS patients on glomerular cell GAG over, lymphocytes from INS patients exhibit a decreasedand HS.
proliferative response to allogeneic cells and to phyto-Methods. Human GECs were cultured with total peripheral
heamagglutinin (PHA) [11–13]. Humoral-mediated im-blood mononuclear cells (PBMCs), PBL, and monocytes from
patients and controls. The amounts of GAG and HS were munity is also affected with a decrease in plasma IgG
assessed using a cationic membrane after metabolic labeling. [2, 14] caused by modifications in the IgM-IgG switch
Results. In coculture with GECs, mononuclear cells from
[15]. Finally, the effectiveness of immunosuppressivecontrols decreased total epithelial cell GAG (230% with
drugs such as corticosteroids and cyclosporine A to in-PBMC, P , 0.05; 225% with PBL, P , 0.02; 219% with
monocytes, P , 0.05). Particularly HSs were decreased (236% duce remission demonstrates that changes in the immune
with PBMC, P , 0.05; 227% with PBL, P , 0.02; and 219% system contribute to the physiopathology of INS [16–19].
with monocytes, P , 0.05). When GECs were in coculture The involvement of a circulating factor in INS is sug-
with PBL from INS patients, the decrease in GAG and HS
gested by transient proteinuria in newborns from womenwas significantly greater in comparison to control PBL (210%,
with INS [20] and by proteinuria in rats after injectionP , 0.02; 210%, P , 0.02, respectively, for GAG and HS).
Moreover, supernatants of stimulated PBMCs from patients of sera from INS patients [21, 22]. The relapse of protein-
decreased also GAG and HS in comparison with controls uria after renal transplantation and the remission after
(213%, P , 0.02; 215%, P , 0.02, respectively, for GAG immunoadsorption of plasma from patients support thisand HS).
hypothesis [23]. Moreover, serum from patients increasesConclusion. These data provide direct evidence that PBLs
glomerular permeability to albumin in an in vitro modelfrom INS patients are able to decrease GEC HS as previously
shown with plasma from patients. This might be instrumental [24]. The cellular origin of this factor is unknown. Never-
in the onset of albuminuria. theless, proteinuria can be induced in rats by a factor
synthesized by T-cell hybridomas [25] and by superna-
tants of mononuclear cells from INS patients [26, 27].
Lymphocyte function seems to be involved in the phys- These results strongly suggest that lymphocytes may be
iopathology of idiopathic nephrotic syndrome (INS) [1]. the cells that secrete this factor(s). Furthermore, a solu-
Subsequently, the association of INS with thymoma or ble immune response suppressor factor [28] and a vascu-
Hodgkin’s disease [1–4] and with allergic phenomena lar permeability factor that may modify the glomerular
permeability [29–32] are derived from lymphocytes from
INS patients.Key words: glomerular epithelial cell, albuminuria, thymoma, Hodg-
kin’s disease, proteinuria, circulating factor, mononuclear cells. Previous studies have demonstrated a decrease in the
polyanion heparan sulfate (HS) chains on kidney biop-Received for publication January 21, 1999
sies of patients with INS [33], and we have recently re-and in revised form August 16, 2000
Accepted for publication September 14, 2000 ported that plasma from children with INS is able to
decrease the synthesis of secreted and cellular glycosami-Ó 2001 by the International Society of Nephrology
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Table 1. Clinical datanoglycans (GAGs) in vitro, particularly the synthesis of
glomerular cell HS [34]. The circulating factor in plasma Urinary Urinary Plasma
prot/creat protein albuminfrom patients might have an effect on glomerular cells
Patient Diagnosis Treatment g/mmol g/l g/lby decreasing HS and could contribute to albuminuria.
1 INS-Rel WT 0.52 3.33 9.43The present study was carried out to determine
2 INS-Init WT 1.93 16.0 10.85
whether mononuclear cells from INS patients and from 3 INS-Rel WT 3.33 27.0 18.6
4 INS-Init WT 1.33 4.8 14.6controls could modify human glomerular epithelial cell
5 INS-Init WT 0.98 3.5 12.6(GEC) HS and chondroitin/dermatan sulfates (CS), as
6 INS-Rel WT 0.66 10.0 30.8
previously shown with INS plasma. We studied the effect 7 INS-Rel Pred 0.83 3.06 30.7
8 INS-Rel Pred 0.3 1.87 NAof mononuclear cells from INS patients in coculture with
9 INS-Rel Pred 0.89 4.2 12.5human GECs and the effect of peripheral blood mono-
10 INS-Rel Pred 0.14 1.1 32
nuclear cell (PBMC) supernatants on the cell-bound 11 INS-Rel Pred 0.6 3.0 15.1
12 INS-Rel Pred 0.8 1.12 NAfraction and the secreted fraction of epithelial cell HS
Abbreviations are: INS, idiopathic nephrotic syndrome; Init, initial episode;and CS.
Rel, relapse; WT, without treatment; Pred, treated with prednisolone; NA, not
available.
METHODS
Patients
Louis, MO, USA) at 378C. After 30 minutes, they wereThe definition of INS and of response to steroid ther-
pushed through a 500 mesh sieve. GECs were recoveredapy was those used by the International Study for Kidney
in RPMI 1640 culture medium (GIBCO, Grand Island,Disease in Children [35]. Mononuclear cells were ob-
NY, USA) supplemented with 10 mmol/L HEPEStained from 12 children with INS, at initial episode for
(Sigma), 2 mmol/L l-glutamine (GIBCO), 50 UI/mL3 children and at relapse for 9 children. They all had a
penicillin-50 mg/mL streptomycin (GIBCO) and 20%typical presentation of the disease and responded to the
heat-inactivated fetal calf serum (FCS; GIBCO). GECssteroid treatment. None had received any other immuno-
were incubated in bovine gelatin (Sigma)-coated culturesuppressive drug, particularly cyclosporine A. On ac-
flasks at 378C, 5% CO2. GECs were identified by theircount of the small volume of blood samples, mononu-
typical morphology on light microscopy (Fig. 1), positive
clear cells of each child were studied either in coculture staining with cytokeratine and vimentine, and negative
or in preparation of supernatants. Table 1 summarizes staining for factor VIII and actin [37–39]. Immunohisto-
the clinical features of the INS patients. PBMCs were logical techniques were also assessed, and a positive stain-
collected from patients 1, 4, 8, 9, and 12. Peripheral blood ing was observed with monoclonal antibodies against
lymphocytes (PBLs) were collected from patients 1, 2, common acute lymphocytic leukemia antigen (CALLA)
3, 5, 6, 7, and 12, and monocytes were collected from and Wilms’ tumor (WT-1) [40, 41]. Finally, cGMP syn-
patients 3, 5, 6, 7, and 12. Supernatants were prepared thesis was increased when cells were stimulated by atrial
from PBMCs from patients 1, 2, 3, 4, 8, 9, 10, and 11. natriuretic peptide [42]. Subcultures of third and fourth
passages were used.Blood samples
Blood samples were collected on ethylenediaminetet- Mononuclear cell preparation
raacetic acid (EDTA). Control blood samples were ob- Peripheral blood mononuclear cells were isolated
tained from healthy volunteers (20 to 36 years) without from venous blood by Ficoll density centrifugation (Fi-
proteinuria or medication. Preliminary studies showed coll-Paque; Pharmacia Biotech, Quebec, Canada). The
that age had no influence on the action of mononuclear cells were collected and washed in RPMI 1640 supple-
cells on glomerular cell GAG, CS, and HS. mented with 10% heat-inactivated FCS.
The study was approved by the ethics committee of Peripheral blood lymphocytes were separated from
our institution. the PBMC population by removing the monocytes that
adhered to plastic: The PBMCs were resuspended at 4 3
Glomerular cell culture 106 PBMC/mL in medium supplemented with 10% FCS
Glomerular epithelial cells were obtained from the and incubated for one hour at 378C, 5% CO2 in a plastic
normal cortex of kidneys removed from patients who culture flask. The nonadherent PBL were collected by
had unilateral nephrectomy for malignant neoplasm or gentle washing with medium. The cell population ob-
urologic malformation, as previously described [36]. tained in these conditions contained less than 0.2% non-
Briefly, the renal cortex was homogenized and pushed lymphocyte cells by fluorescence-activated cell sorter
through 80 and 140 mesh sieves. The glomeruli were analysis after incubation with monoclonal antibodies
(data not shown).incubated with 300 U/mL collagenase type I (Sigma, St.
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Fig. 1. Human glomerular epithelial cells (GECs). (A) General aspect of a confluent culture on light microscopy. (B) After immunohistologic
staining with monoclonal antibodies against CALLA on isolated cells. (C) After immunohistologic staining with monoclonal antibodies against
WT-1 on isolated cells. Negative controls showed no staining. (A 3400; B and C 3700).
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Monocytes were detached from the plastic by incuba- both techniques. Moreover, supernatants of GEC cul-
tion of the adherent cells in medium containing EDTA tures were also treated with chondroitinase ABC or
5 mmol/L and 20% FCS for 15 minutes at 48C. heparitinase or both enzymes. We found that there was
Supernatants of PBMCs from patients or controls no nonspecific binding on the cationic membrane; in-
were obtained by incubation of 2 3 106 PBMC/mL in deed, after treatment with both enzymes, no binding of
medium (RPMI 1640) containing 10% FCS and 1 mg/mL 35S-labeled molecules was detected, and the amounts of
PHA (Sigma) at 378C, 5% CO2. After 48 hours, cells HS and CS were the same than with the dot-blot tech-
were centrifuged, and the supernatants were removed nique. For all experiments, cells were grown in parallel
and stored at 2808C until processed. Supernatants were in exactly the same experimental conditions. Cells were
heat inactivated before added to the cultures. scraped and dissolved in Tris buffer containing 2 mol/L
urea. The amounts of cell protein for each well were
Quantitation of GAG and HS measured using the Bio-Rad protein assay.
Glomerular epithelial cells were cultured to confluent The results were expressed as cpm/mg of cell protein
monolayers in 24-well plates. The confluent monolayers for each test condition divided by cpm/mg of cell protein
of GECs were at the bottom of the plates, whereas the for the control condition.
mononuclear cells were incubated in inserts (Falcon, Preliminary studies showed that secreted and cell-
Meylan, France) with pores of 0.4 mm to prevent a direct bound HS and CS fractions of mononuclear cells after
contact between the two cell types and to allow the 24 hours of incubation in medium or in coculture with
passage of molecules. PBMCs or PBLs (0.8 3 106/well, glomerular cells were insignificant. Mononuclear cells
2 3 106 cells/mL) and monocytes (0.05 3 106/well, 0.125 3 in inserts were then analyzed with the supernatants of
106 cells/mL) were incubated in inserts. The cocultures GECs.
were incubated in SO4-free medium containing 50 mCi/mL
Na235SO4 (specific activity: 1050 to 1600 Ci/mmol; Amer- Study of GAG chains depolymerization
sham, Arlington Heights, IL, USA) and 5% FCS. For Glomerular epithelial cells were cultured without
some experiments, GECs were incubated with 5 and mononuclear cells or in coculture with control PBL in
10% supernatants of PBMCs in SO4-free medium con- inserts or with patient PBL in inserts in 24-well plates
taining 50 mCi/mL Na235SO4, without FCS. All experi- in medium with Na235SO4 for 24 hours, in the same condi-ments were conducted in duplicate. tions as for quantitation of GAG. Culture medium of
After 24 hours, the secreted and the cell-bound frac- each condition was collected and centrifuged. Superna-
tions of HS and GAG were quantitated as previously
tants were treated by b-elimination to cleave GAG
described [34, 43]. Briefly, GAGs were extracted in Tris
chains from the core proteins, and proteins were re-buffer containing 8 mol/L urea and 0.1% Triton X-100,
moved by phenol extraction [46].heated at 908 for 20 minutes, and bound to a cationic
nylon membrane (Zeta-probe; Bio-Rad Laboratories, Polyacrylamide gel electrophoresis
Hercules, CA, USA) using a dot-blot technique. Two
The labeled samples were loaded on a polyacrylamidefractions of each sample were pulled through the blot by
gradient gel [47]. Each sample was loaded in duplicate.vacuum. The first was incubated in Tris buffer containing
The gel was run at 400 V for three hours. The 35S-labeled0.65 mol/L NaCl for one hour, washed, and dried. The
GAG chains were revealed by autoradiography. Theother was washed and incubated for 2 3 90 minutes with
standard samples showed that GAGs with molecularnitrous acid in order to depolymerize and release HS
weight above 5000 D were detected on the gel.chains [44], and then treated as the first. In this condition,
only GAG-bearing CS chains remained bound to the Gel filtration
membrane. The blots were then cut for scintillation
Glycosaminoglycan chains’ size distribution was ana-counting. The amount of HS was evaluated by the differ-
lyzed on a Sephadex G-50 column (Pharmacia) elutedence between total cpm and cpm obtained after nitrous
in 10 mmol/L NH4HCO3 buffer. The column was loadedacid treatment. The method was validated by comparison
with the labeled GAG chains; 0.5 mL fractions werewith Diethylaminoethyl (DEAE)-Sephacel chromatog-
collected, and GAG chains were quantitated by scintilla-raphy and gel filtration [34, 45]. Radiolabeled GAGs
tion counting. The samples were studied before and afterwere isolated by DEAE-Sephacel chromatography after
treatment with heparitinase (Sigma).b-elimination and phenol extraction to remove the core
proteins. GAGs were than treated either with chondro-
Statisticsitinase ABC (Sigma), either with heparitinase (Seika-
Data are expressed as the mean 6 SE. N representsgaku, Tokyo, Japan), either with both enzymes. We
the number of experiments. The Wilcoxon signed-rankshowed that glomerular cell GAGs were only HS and
CS, and the proportion of CS and HS was similar with test was used to evaluate the significance of the results.
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Fig. 2. Effect of mononuclear cells from nor-
mal controls (j) and idiopathic nephrotic
syndrome (INS; (h) patients on glomerular
epithelial cells (GEC) heparan sulfate (HS)
and chondroitin/dermatan sulfates (CS).
GECs were cocultured with PBMCs, mono-
cytes, or PBLs for 24 hours in medium with
35S for metabolic labeling of GAG. HS and
CS were quantitated as described in the Meth-
ods section. The results are expressed as
mean 6 SE of the ratios of the cpm/mg cell
protein when GECs were in coculture with
mononuclear cells divided by cpm/mg cell
protein when GECs were in medium without
mononuclear cells, of each experiment. *P ,
0.02; **P , 0.05, in comparison to the situa-
tion with medium without mononuclear cells
whose ratio is 1 (horizontal dashed line). N 5
5 for PBMCs (patients 1, 4, 8, 9, and 12) and
monocytes (patients 3, 5, 6, 7, and 12), N 5 7
for PBLs (patients 1, 2, 3, 5, 6, 7, and 12).
RESULTS case, we observed that PBLs from INS patient decreased
more GAG and HS than PBLs from control. We didEffect of mononuclear cells from controls and INS
not observe a difference of effects of mononuclear cellspatients on glomerular epithelial cell GAG, HS,
from INS patients with steroid treatment or withoutand CS
treatment, and no difference between patients during
When GECs were cocultured with control mononu- the initial episode of disease or in relapse.
clear cells, the glomerular cell GAG decreased signifi- Chondroitin/dermatan sulfates decreased significantly
cantly (0.70 6 0.02, P 5 0.04 with PBMCs; 0.81 6 0.02, when GECs were in coculture with PBMCs from controls
P 5 0.04 with monocytes; and 0.75 6 0.03, P 5 0.02 with and from patients (0.87 6 0.04, P 5 0.04, and 0.83 6
PBL in comparison with medium without mononuclear 0.05, P 5 0.04, respectively) and with monocytes from
cells). When GECs were in coculture with PBL from controls and from patients (0.80 6 0.04, P 5 0.04, and
patients, the decrease in GAG was significantly more 0.80 6 0.04, P 5 0.04, respectively; Fig. 2). In coculture
important than when GECs were in coculture with con- with PBMCs and with monocytes, the decrease in glo-
trol PBL (0.65 6 0.05 with PBL from patients, P , 0.02 merular CS was similar with control mononuclear cells
in comparison to medium without mononuclear cells and and with patient mononuclear cells. When GECs were
P , 0.02 in comparison with coculture with control PBL). in coculture with control PBL and with patient PBL, CS
As shown in Figure 2, when GECs were in coculture decreased significantly (0.83 6 0.03, P 5 0.02, and 0.74 6
with PBMCs from controls and from patients, HS de- 0.06, P , 0.02, respectively). In coculture with PBLs, CS
creased significantly (0.64 6 0.03, P 5 0.04, and 0.70 6 decreased significantly more with PBLs from patients in
0.04, P 5 0.04, respectively). When GECs were in cocul- comparison with PBLs from controls (P , 0.05; Fig. 2).
ture with monocytes, HS decreased only with monocytes With control or patient PBMCs and PBLs, the effect
from controls, whereas monocytes from patients induced was more important on HS than on CS, whereas with
no significant change in HS (0.81 6 0.02, P 5 0.04, and control or patient monocytes the effect was similar on
0.85 6 0.05, NS, respectively, with control monocytes HS and CS, but smaller than the effect of PBLs and
and with patient monocytes). In coculture with PBMCs PBMCs on HS. With patient PBMCs and PBLs, glomer-
and monocytes, the decrease in glomerular cell HS was ular cell HS and CS decreased significantly, whereas with
similar with control mononuclear cells and with patient monocytes only CS decreased significantly.
mononuclear cells.
Effect of mononuclear cells from controls and INSWhen GECs were in coculture with PBLs from con-
patients on the secreted and cell-bound fractions oftrols and from patients, HS deceased significantly (0.73 6
GEC HS and CS0.03, P 5 0.02, and 0.63 6 0.05, P , 0.02, respectively).
In coculture with patient PBLs, glomerular cell HS de- As shown in Figure 3A, the effect on the secreted
creased significantly more than in coculture with control fraction of glomerular cell HS induced by control and
PBLs (P , 0.02; Fig. 2). For each experiment, GECs INS patient PBMCs, monocytes, and PBLs was very
were in coculture with PBLs from one INS patient in similar to the effect on the total HS (Fig. 2). The effect
on HS induced by PBMCs and PBLs was more importantcomparison with PBLs from one control, and in each
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Fig. 3. Effect of PBMCs, PBLs, and mono-
cytes from normal controls (j) and INS
patients (h) on the secreted (A) and the
cell-bound (B) fractions of GEC HS and CS.
GECs were cocultured with PBMCs, mono-
cytes, or PBLs for 24 hours in medium with
35S for metabolic labeling of GAG. The se-
creted (A) and the cell-bound (B) fractions
of HS and CS were quantitated as described
in the Methods section. The results are ex-
pressed as mean 6 SE of the ratios of the
cpm/mg cell protein when GECs were in co-
culture with mononuclear cells divided by
cpm/mg cell protein when GECs were in
medium without mononuclear cells, of each
experiment. *P , 0.02; **P , 0.05, in compari-
son to the situation with medium without
mononuclear cells whose ratio is 1 (dashed
horizontal line). N 5 5 for PBMCs (patients
1, 4, 8, 9, and 12) and monocytes (patients 3,
5, 6, 7, and 12), N 5 7 for PBLs (patients 1,
2, 3, 5, 6, 7, and 12).
than the effect induced by monocytes, as it was shown on the total and secreted HS and CS (Fig. 3B). Although
the effect of PBMCs and PBLs was again more importantfor the total HS. When the effect of mononuclear cells
from patients was compared with the effect of mononu- than the effect of monocytes, the range of the decrease
in HS and in CS was comparable regardless of the mono-clear cells from controls, we observed that PBLs from
patients decreased the secreted fraction of glomerular nuclear cells. Moreover, there was no difference between
the effect of mononuclear cells from controls and fromcell HS significantly more than PBLs from controls,
whereas there was no significant effect of monocytes patients, except for monocytes from patients, which did
not induce a significant decrease in the cell-bound frac-from patients on HS in comparison with monocytes from
controls. tion of HS.
The effect on the secreted fraction of glomerular cell
Effect of supernatants of stimulated PBMCs from INSCS in coculture with control mononuclear cells was only
patients or controls on glomerular epithelial cellsignificant with monocytes. Control PBMCs and PBLs
GAG, HS, and CSdid not induce any modification on this fraction. In con-
trast, PBMCs, PBLs, and monocytes from patients all When GECs were cultured with medium containing
5% supernatants of PHA-stimulated PBMC from INSdecreased the secreted fraction of CS (Fig. 3A).
The effect on the cell-bound fraction of glomerular patients, total GAG, HS, and CS decreased significantly
in comparison with supernatants of PHA-stimulatedcell HS and CS was different from the effect observed
Birmele et al: HS in nephrotic syndrome 919
Fig. 4. Effect of supernatants from stimu-
lated PBMCs from INS patients on the secreted
and cellular fractions of GEC HS (j) and CS
( ). PBMCs from INS patients or controls
were cultured for 48 hours in medium with
10% FCS and 1 mg/mL PHA. Supernatants
were removed and added at 5% to medium
with 35S for metabolic labeling of GAG. GECs
were cultured for 24 hours in this medium.
HS and CS were quantitated as described in
the Methods section. The results are expressed
as mean 6 SE of the ratios of the cpm/mg
cell protein when GECs were cultured with
supernatants of PBMCs from INS patients di-
vided by cpm/mg cell protein when GECs were
cultured with supernatants of PBMCs from
controls, of each experiment. *P , 0.02 for
the situation with supernatants from patients
in comparison to controls. No difference is
a ratio of 1 (dashed horizontal line). N 5 8
(patients 1, 2, 3, 4, 8, 9, 10, and 11).
PBMCs from normal volunteers (0.87 6 0.03, P , 0.02, treated with heparitinase, the profiles were changed with
the presence of degradation products.0.85 6 0.05, P , 0.02, and 0.89 6 0.02 P , 0.02, respec-
tively, for GAG, HS, and CS; N 5 8). As shown in Figure
4, these modifications were prevalent on the secreted
DISCUSSIONfractions of HS and CS, whereas the decrease of the cell-
In this study, we demonstrated that mononuclear cellsbound fractions of HS and CS was not significant. For
decreased glomerular cell HS and CS when both celleach experiment, GECs were in coculture with the super-
types were in coculture. This effect was induced by con-natant of activated PBMCs from one INS patient in
trol mononuclear cells, but especially by INS patientcomparison with the supernatant of activated PBMCs
cells.from one control, and in each case, we observed that
First, when GECs were in coculture with PBMCs, glo-the supernatant of activated PBMCs from INS patient
merular cell HS and CS decreased. This effect wasdecreased more GAG and HS than the supernatant of
greater on HS. The decrease of HS was induced in partic-activated PBMCs from control. No difference of effects
ular by PBLs and less by monocytes. The decrease ofof PBMC supernatants from INS patients with steroid
CS was induced by PBLs and monocytes in a similartreatment or without treatment was observed, nor was
manner. Finally, the decrease of HS involved equallythere a difference between patients during the initial
the cell-bound and the secreted fractions, whereas theepisode of disease or in relapse.
decrease of CS involved only the cell-bound fraction,When GECs were cultured with medium containing
except for monocytes, which induced a decrease in both10% supernatants of PHA-stimulated PBMCs, secreted
fractions. These results indicated that mononuclear cellsHS and CS decreased in the same manner as with 5%
from normal allogeneic controls were able to decreasesupernatants (data not shown).
glomerular cell GAG, particularly HS. It has been pre-
Study of GAG chains depolymerization viously shown that activated lymphocytes are able to
release and degrade HS of endothelial cells and of thePolyacrylamide gel electrophoresis. When superna-
extracellular matrix [48, 49], but to the best of our knowl-tants of GEC cultures were studied by polyacrylamide
gel electrophoresis (PAGE), we observed a similar mi- edge, this is the first study that emphasizes the direct
effect of mononuclear cells, especially PBLs on glomeru-gration of GAG chains in the three conditions (Fig. 5):
without mononuclear cells (lanes I), in coculture with lar cell HS. Studies of GAG chains on polyacrylamide
gradient gel and gel filtration showed that there was nocontrol PBLs (lanes II), and in coculture with patient
PBLs (lanes III). All smears were on the same level, depolymerization of GAG chains when GECs were in
coculture with control PBL in comparison with mediumindicating that there was no depolymerization of HS
chains. without mononuclear cells, indicating that the decrease
in glomerular cell HS induced by control PBL was notGel filtration. Elution profiles on the Sephadex G-50
column of 35S-labeled GAG chains were similar in the induced by an increased degradation of these chains.
Finally, our data did not permit explanation of the morethree conditions, and no degradation products were ob-
served. In contrast, when the samples were previously pronounced effect on HS particularly by PBMCs and
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viously [34]. Indeed, we demonstrated that glomerular
cell HS and CS are decreased when GECs are incubated
with INS plasma in comparison with control plasma,
and in these conditions, the cell-bound and the secreted
fractions of HS and CS are decreased. Finally, PAGE
and gel filtration showed that there was no depolymeriza-
tion of GAG chains. Thus, the decrease in glomerular
cell HS induced by patient PBL was probably induced
by a decrease in synthesis of HS chains, as it was shown
with plasma from INS patients.
In this study, the decrease in HS and CS in our in vitro
model was induced by one or various factors secreted
or released by PBLs, since there was no direct contact
between PBLs and GECs, and supernatants of stimu-
lated PBMCs had the same action. This is in agreement
with studies in which supernatants of mononuclear cells
from INS patients increased glomerular permeability to
albumin in animal models [26, 27]. Moreover, mononu-
clear cells from INS patients induced a decrease in poly-
anions in vitro on rat kidney tissue sections [50]. This
factor(s) could be the plasma-borne circulating factor(s)
whose involvement was suggested in INS by transient
proteinuria in newborns from women with INS [20], by
proteinuria in rats after injection of sera from INS pa-
tients [21, 22], by relapse of proteinuria after renal trans-
plantation and a remission after immunoadsorption of
the plasma [23], and by an increase in glomerular perme-
ability induced by serum from patients in an in vitro
model [24].
The decrease in GAG might be involved in the physio-
pathologic mechanism of proteinuria in INS. Indeed, HS
Fig. 5. Polyacrylamide gradient gel of glomerular cell GAG chains. had a role in glomerular permeability to albumin. HS is
GECs were cultured for 24 hours in medium with 35S for metabolic
the major GAG of the glomerular basement membranelabeling of GAG. After removing of proteins from the supernatants
of the cultures, the samples were loaded on a polyacrylamide gradient [51, 52] and is present in the polyanionic glycocalyx of
gel, each sample in duplicate: culture in medium without mononuclear the apical plasma membrane of GEC [53]. A decrease of
cells (lanes I), coculture with control PBL (lanes II), and coculture
polyanions has been demonstrated during albuminuriawith patient PBL (lanes III). GAG chains were revealed by autoradiog-
raphy. states in various studies [54, 55], particularly in INS in
relapse, whereas normalization has been observed in
remission [56–59]. The role of HS with regard to other
polyanions is most prevalent in the glomerular perme-
PBLs in comparison with the effect on CS. However, ability [60]. A decrease in HS in the glomerular basement
this effect was not induced by an increased degradation. membrane has been described in disease states in which
More importantly, mononuclear cells from patients glomerular permeability to albumin is increased [61],
varied from those of controls by at least three ways. especially in INS [33] and in experimental nephrotic syn-
First, PBLs from patients decreased the secreted fraction drome in animal models [62, 63]. Moreover, a mono-
of HS more importantly than PBL from controls. Second, clonal antibody against glomerular basement membrane
PBMCs and PBLs from patients but not from controls HS was shown to induce acute selective proteinuria in
decreased the secreted fraction of glomerular cell CS. rats [64]. Thus, our data showing that PBL from INS
Finally, in agreement, supernatants of PHA-stimulated patients decrease GAG and particularly HS indicate that
PBMCs from patients decreased significantly more the PBLs contribute to the increase of glomerular perme-
secreted HS and CS than supernatants of PHA-stimu- ability to albumin. Further experiments will state which
lated PBMCs from controls. are the factors involved in the cross-talk between the
The effect of PBL and of supernatants of stimulated two cells and the exact implication of this phenomenon
PBMC from patients is comparable to the effect of in the pathogenesis of INS.
The plasma factor(s) was secreted by lymphocytes, butplasma from INS patients, which we have shown pre-
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